Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.9% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
0
users have commented on this narrative
36
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.0% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
SCHOTT Pharma KGaA
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Advanced Drug Delivery And Capacity Investments Will Shape Future Success
Key Takeaways Expanding high-value solutions and strategic partnerships fuel revenue growth, improved margins, and long-term financial stability in advanced drug delivery packaging markets. Sustainability initiatives and operational efficiency measures enhance profitability, competitive positioning, and support ongoing margin and earnings expansion.
View narrative
€29.34
FV
21.3% undervalued
intrinsic discount
9.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
about 13 hours ago
author updated this narrative
Neoenergia
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Brazil Renewables Will Drive Growth Amid Operational Risks
Key Takeaways Neoenergia's focus on renewable expansion and grid modernization aligns with global decarbonization trends, supporting long-term growth and improved operational efficiency. Regulatory clarity, organic customer growth, and disciplined deleveraging strengthen earnings predictability and enhance shareholder returns.
View narrative
R$31.98
FV
16.0% undervalued
intrinsic discount
-3.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
about 13 hours ago
author updated this narrative
Aspen Pharmacare Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Commercial Pharma And GLP-1 Expansion Will Empower Future Progress
Key Takeaways Steady commercial pharma growth through strategic market focus in China and Russia enhances revenue stability. GLP-1 and insulin manufacturing expansion offers substantial long-term revenue and margin growth potential.
View narrative
R123.66
FV
9.4% undervalued
intrinsic discount
2.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
22
users have followed this narrative
about 13 hours ago
author updated this narrative
Valmet Oyj
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Operating Model Reforms And Biomaterial Focus Will Unlock Efficiency
Key Takeaways Simplified structure, local accountability, and digitalization initiatives are set to improve margins, stability, and recurring high-margin service revenues. Strategic focus on circularity, sustainability, and automation positions Valmet for long-term growth and expanding high-margin order backlog.
View narrative
€29.78
FV
1.5% overvalued
intrinsic discount
4.09%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
27
users have followed this narrative
about 13 hours ago
author updated this narrative
Logista Integral
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Pharma Italia Integration And SGEL Libros Acquisition Drive Growth, But Declining Tobacco Sales Pose Risks
Key Takeaways Logista's diversification strategy and acquisitions in sectors like pharmaceuticals could drive future revenue growth and strengthen its market position. Effective management of tobacco-related factors and a robust dividend policy suggest stable shareholder returns and potential attractiveness despite external economic challenges.
View narrative
€31.63
FV
7.9% undervalued
intrinsic discount
-48.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
23
users have followed this narrative
about 13 hours ago
author updated this narrative
Steadfast Group
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Investments In InsurTech And International Expansion Will Improve Operational Efficiency
Key Takeaways Competitive pricing, premium rate increases, and strategic acquisitions in international markets bolster revenue growth and operational efficiencies. Technology investments and management strengthening are anticipated to improve net margins through streamlined operations and enhanced risk management.
View narrative
AU$6.77
FV
9.0% undervalued
intrinsic discount
4.71%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
about 13 hours ago
author updated this narrative
B&M European Value Retail
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Everyday Low Prices And Strategic Expansion Set To Boost Revenue And Strengthen Margins
Key Takeaways Strategic store expansion and disciplined cost management aim to enhance revenue and improve net margins through operational efficiency. Strong cash returns to shareholders via buybacks and dividends signal robust future cash flows and enhance shareholder value.
View narrative
UK£4.04
FV
44.2% undervalued
intrinsic discount
5.65%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
2
users have commented on this narrative
61
users have followed this narrative
about 13 hours ago
author updated this narrative
SCOR
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Elevated Climate Risk And Diversification Will Unlock Reinsurance Value
Key Takeaways SCOR's data-driven underwriting and business diversification enhance profitability, resilience, and open access to new markets amid rising reinsurance demand from global volatility. Strong capital management and Life & Health growth position SCOR to benefit from regulatory shifts and ESG trends, supporting revenue expansion and shareholder value.
View narrative
€30.81
FV
7.8% undervalued
intrinsic discount
4.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
about 13 hours ago
author updated this narrative
Ajanta Pharma
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Aging Demographics And Emerging Markets Will Fuel Global Healthcare Demand
Key Takeaways Focus on high-demand therapeutic segments and expansion into emerging markets positions Ajanta Pharma for sustained growth and increased market share. Robust R&D pipeline, manufacturing expansion, and strong financial discipline provide a solid foundation for margin improvement and future growth opportunities.
View narrative
₹3.01k
FV
10.7% undervalued
intrinsic discount
11.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
about 13 hours ago
author updated this narrative
Value any company in seconds
Popular companies